Living with early Parkinson's disease? A clinical trial is exploring a more personalized approach to treatment ↗
(BPT) - When Tony Hindhaugh was diagnosed with Parkinson's disease at age 55, he learned that there are currently no approved therapies that slow the progression of the disease. Current treatments focus primarily on managing symptoms of the progressive brain disorder, leaving patients and families hoping for new options.